Nabilone for non-motor symptoms of Parkinson’s disease: a randomized placebo-controlled, double-blind, parallel-group, enriched enrolment randomized withdrawal study (The NMS-Nab Study)

Overview of attention for article published in Journal of Neural Transmission, May 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Readers on

mendeley: 70 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 10,269 followers.

The plan for the NMS-Nab Study (Nabilone - a synthetic cannabinoid - for non-motor symptoms of #Parkinsons) - a mono-centric phase II, randomized, placebo-controlled, double-blind, parallel-group, enriched enrollment withdrawal study - has been published h